News

Bexion Pharmaceuticals Unveils Promising Cancer Research Posters

Bexion Pharmaceuticals Unveils Promising Cancer Research Posters

Bexion Pharmaceuticals Showcases Key Research at ASCO 2026

Bexion Pharmaceuticals, Inc. is making great strides in the field of oncology with its innovative drug candidate, BXQ-350. This clinical-stage biopharmaceutical company is dedicated to developing effective therapies aimed at treating solid tumor cancers and alleviating chemotherapy-induced peripheral neuropathy (CIPN). As part of this commitment, Bexion is participating in the prestigious American Society for Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026, which will take place over several days. This event is a crucial platform for researchers and healthcare professionals in the cancer field.

Groundbreaking Findings from BXQ-350 Studies

At the upcoming ASCO symposium, Bexion will present several poster sessions detailing the latest findings from their studies involving BXQ-350. This first-in-class therapeutic agent has undergone significant clinical trials examining its safety and efficacy among patients diagnosed with metastatic colorectal carcinoma (mCRC). Each presented study sheds light on the potential benefits of BXQ-350 in managing challenging cancers.

First Poster Highlights

The first poster features an abstract titled "BXQ-350 efficacy and safety evaluation in first-line mCRC patients: A phase 1b/2 study of BXQ-350, a first-in-class sphingolipid metabolism modulator, in combination with mFOLFOX7 plus bevacizumab in newly diagnosed metastatic colorectal carcinoma." This study, led by Dr. Reema Patel, will be presented in Poster Session C dedicated to colon, rectum, and anus cancers. It aims to provide insights into how BXQ-350 performs alongside standard treatment protocols.

Second Poster Presentation Details

The second poster elaborates on a similar efficacy and safety analysis of BXQ-350 in conjunction with mFOLFOX7 and bevacizumab for patients diagnosed with metastatic colorectal carcinoma. Presented by Dr. Tariq Arshad, this trial represents a significant step in understanding the therapeutic landscape for patients undergoing treatment for these types of cancers.

Additional Research and Insights

Bexion's third poster will discuss the effect of BXQ-350 on oxaliplatin-induced CIPN. This study evaluates the efficacy and safety of BXQ-350 in patients treated with FOLFOX7 and aims to uncover strategies to alleviate discomfort from chemotherapy. Michael Gazda, Ph.D., will present these findings, focusing on how BXQ-350 may provide significant relief to patients experiencing CIPN.

The Significance of BXQ-350

Bexion's lead product, BXQ-350, offers a novel therapeutic alternative that combines a multifunctional sphingolipid activator protein with phospholipids. Multiple Phase 1 trials have highlighted a robust safety profile for the drug, demonstrating efficacy across various solid tumors. With potential applications beyond oncology, including relief from CIPN, BXQ-350 represents an innovative shift in cancer therapy and patient care.

About Bexion Pharmaceuticals

Bexion Pharmaceuticals stands at the forefront of biotherapeutic development as it embarks on creating a new generation of treatments aimed at solid tumor cancers and CIPN. The company is exploring broader applications in other cancer types and neuropathic pain indications. With successful enrollment in its Phase 1b/2 study evaluating BXQ-350, Bexion is poised to make meaningful contributions to patient care and outcomes as it continues its clinical trials.

Investor Relations and Media Contact Information

Bexion Pharmaceuticals encourages further inquiries from investors and media representatives. Joyce LaViscount is available for contact and can provide additional information about the company's ongoing projects and strategic objectives.

Frequently Asked Questions

What is BXQ-350?

BXQ-350 is a first-in-class biologic therapy developed by Bexion Pharmaceuticals for treating solid tumors and chemotherapy-induced peripheral neuropathy.

When will Bexion present its research?

Bexion will present its research at the ASCO Gastrointestinal Cancers Symposium, taking place from January 8-10, 2026.

Who will present the findings?

Dr. Reema Patel, Dr. Tariq Arshad, and Michael Gazda, Ph.D., will lead the presentations on the efficacy and safety of BXQ-350.

What are the main objectives of the poster presentations?

The objectives are to showcase the efficacy, safety, and potential benefits of BXQ-350 in treating metastatic colorectal carcinoma and CIPN.

How can I contact Bexion Pharmaceuticals for more information?

You can reach out to Joyce LaViscount for inquiries regarding investor relations or media requests.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Goodwill's ReThink Fashion: Textiles to Runway Art

Updated Category News Views 3

Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...

Continue Reading
VitalCore Pioneers Jail Behavioral Health Expansion

Updated Category News Views 4

The Big Move in Correctional Healthcare VitalCore Health Strategies has made an impressive move with the opening of a 60-bed Behavioral Health Unit at Shawnee County Jail in Topeka, Kansas. The unit, part of a $21 million expansion completed on August 24, is set to change the landscape for inmates needing mental health and substance use treatment. This isn't just a slap...

Continue Reading
South Florida Donor Network Honors 52 Heroic Donors

Updated Category News Views 1

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...

Continue Reading
Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 2

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Aflac's $200M Milestone in Cancer Charity Support

Updated Category News Views 0

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

Continue Reading
Muscle Car Fever Revs Up in New Global TV Series

Updated Category News Views 2

Chasing the Dream on Wheels Amid the buzz of New York, there's a roar building up that's hard to ignore. It's a sound that echoes through time, capturing the imagination of petrol heads everywhere—those legendary American muscle cars are back in the limelight. I mean, who hasn't dreamt of launching down a highway in a '69 Ford Mustang? 'The Hunt for Rolling Treasure' is...

Continue Reading
Give Lively & Change Simplify CA Nonprofit Compliance

Updated Category News Views 0

A Fresh Wind Blowing for California Nonprofits So, here's a twist in the nonprofit world that's stirring the pot just right. Give Lively and Change have partnered up to tackle the thorny issue of regulatory compliance in California. It's a big win for the nonprofits looking to keep fundraising through Give Lively without getting tangled in the bureaucratic web spun up by...

Continue Reading
Facility Solutions Group Climbs to Top 18 Electrical Spot

Updated Category News Views 0

FSG Shines Brightly in Electrical Contractor Rankings Climbing the ladder is no easy feat, but Facility Solutions Group (FSG) has managed to climb, all the way to the #18 spot on Electrical Construction & Maintenance (EC&M) magazine's revered list of the Top Electrical Contractors in the U.S. It’s up from their previous rank of 22. When you think about the competitive...

Continue Reading
Webinar Highlights Workforce Skills and AI Tools

Updated Category News Views 3

The Shift Towards Skills-Based Talent Development The labor market's in a whirl, folks. Employers are scrambling to adapt to rapid changes, chasing after 'skills intelligence' like it's going out of style. On September 24, University of Phoenix, with its band of partners including Jobs for the Future and Skillmore™, will dig into this very topic. This upcoming webinar...

Continue Reading
Global Communication Works Opens SignlLabs™ AI Licensing

Updated Category News Views 23

AI Signaling Moves Beyond GCW's Own Clients Remember when we first looked at GCW's SignlLabs and the idea of helping brands show up inside ChatGPT, Gemini, Claude, Copilot and Perplexity? Well, Global Communication Works is taking the next step. Instead of keeping its AI Signaling playbook inside the agency walls, GCW is now opening SignlLabs up for licensing

Continue Reading

Top 5 Most Recently Viewed Articles

Netflix Shares Surge as Market Reacts to Trump's Statements

Updated Category News Views 279

Netflix Stock Experiences Turbulence Shares of Netflix (NASDAQ: NFLX) showed significant volatility on a Monday morning, following unexpected comments made by former President Donald Trump on a social media platform. His post raised alarms about potential tariffs on films produced outside the country, causing immediate reactions in the stock market. Trump's Tariff...

Continue Reading
TCL Electronics Maintains Strong Global Shipment Ranking

Updated Category News Views 415

TCL Electronics Achieves Notable Shipment Milestones TCL Electronics Holdings Limited (01070.HK) has recently shared exciting news about its television shipment performance for the first half of 2025. The company's commitment to producing high-quality TVs has resulted in substantial growth, as global shipments reached an impressive 13.46 million units. This marks a...

Continue Reading
Ferrari's Dynamic Share Buyback Program Update

Updated Category News Views 142

Exploring Ferrari's Recent Share Buyback Activities Ferrari N.V. (NYSE/EXM: RACE) has been proactive in managing its shareholder value through an extensive share buyback program. As part of a strategic decision announced back in December 2024, Ferrari committed to buying back shares worth approximately Euro 150 million. This is the sixth tranche of a larger plan that aims...

Continue Reading
Revolutionary Washcloth Design Improves Bathing Experience

Updated Category News Views 165

Introducing an Innovative Washcloth Design An inventive mind has crafted a revolutionary washcloth that transforms the way you clean your body. This newly designed washcloth ensures a more efficient and user-friendly experience, taking away the hassles associated with traditional square washcloths. The inventor envisioned a product that would enhance cleanliness and...

Continue Reading
Exploring Mongolia's Sustainable Business Landscape in 2024

Updated Category News Views 87

Discover Mongolia's Sustainable Business Opportunities Experience the vast possibilities for sustainable business, tourism, and fashion at Mongolian Days 2024, a must-attend event for industry professionals. Get ready to explore Mongolia's untapped potential at the upcoming Mongolian Days 2024, hosted by influential organizations aiming to showcase sustainable business...

Continue Reading